Navidea Biopharmaceuticals Inc.

(NAVB)

By |

Profile

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products, are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Contact Information

Website: www.navidea.com
Email: jlatkin@navidea.com
Main Phone: +1 614 793-7500
Address: 4995 Bradenton Avenue
Address 2: Suite 240
State: OH
City / Town: Dublin
Country: USA
Postal Code: 43017-3552

Issuer Information

Exchange: AMX
CEO: Jed A. Latkin
Employees: 24
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 0.14 $ 0.0049 (3.63%)
Last Price 0.14 Change $ 0.0049 Change % 3.63 Tick N/A
Bid 0.14 Bid Size 20,000.00 Ask 0.14 Ask Size 100.00
Open 0.13 High 0.14 Low 0.13 Prev Close 0.14
Last Trade Volume 159,660 52 Wk Hi 0.45 52 Wk Low 0.13
Market Cap 25.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 181,890,700.00 EPS (TTM) -0.10 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 11
Number of Buys 1 10
Number of Sells 0 1
Net Activity 50000 527694
Last 10 Buys Shares
William J. Regan 1,000
Jed A. Latkin 1,000
Jed A. Latkin 1,000
Jed A. Latkin 1,000
Gordon A. Troup 1,000
Brendan A. Ford 1,000
Michael M. Goldberg 1,000
Michael M. Goldberg 1,000
Brendan A. Ford 1,000
Mark J. Pykett 1,000
Last 10 Sell Shares
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Brent L. Larson 1,000
Frederick O. Cope 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.4 2.4 2.4 2.4
Low Target Price Estimate 2.4 2.4 2.4 2.4
Mean Target Price Estimate 2.4 2.4 2.4 2.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/05/16 04/05/16 04/05/16 04/05/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1